Consultant, US Market Access Strategy – Rare Disease
Eliassen Group, Hagatna, Gu, United States
Consultant, US Market Access Strategy – Rare Disease
Anywhere (Remote)
Type: Contract (W2)
Industry: Life Sciences
Rate: $70.00 – $80.00 per hour (W2)
Job Overview Our client seeks a consultant to drive U.S. market access strategy and launch readiness for a rare disease asset. The role advises on payer analytics, value narrative development, and field enablement to support access decisions across commercial and government channels. The consultant will translate evidence and data into strategic recommendations and partner across functions to ensure integrated launch planning.
Responsibilities
Support development and refinement of U.S. payer strategy for rare disease assets approaching launch.
Conduct payer landscape and access risk assessments across commercial, Medicaid, and specialty payer segments.
Pressure-test launch assumptions related to access timing, utilization management, and contracting scenarios.
Provide structured recommendations on access-related risks and mitigation strategies.
Shape the payer value narrative by translating clinical, unmet need, and HEOR inputs into payer-relevant messaging.
Align the value story across national and regional payer audiences.
Identify evidence or analytics gaps that could affect payer decision‑making pre‑ and peri‑launch.
Analyze claims data, coverage policies, and utilization management trends to generate actionable insights.
Translate data into clear strategic implications for market access leadership.
Support payer segmentation and prioritization based on disease prevalence, payer controls, and policy trends.
Enable field market access and account teams with payer insights, strategic talking points, and analytics‑driven frameworks.
Advise account teams on payer motivations, objections, and decision pathways in rare disease.
Ensure field‑facing materials are strategy‑led and aligned with overall payer positioning.
Collaborate with Market Access, Medical Affairs, HEOR, and Commercial Planning to drive integrated launch readiness.
Act as a market access thought partner in a lean, fast‑moving environment.
Experience Requirements
7–12+ years in market access strategy, payer strategy, or life sciences consulting.
Experience supporting rare disease and/or orphan product launches.
Strong understanding of U.S. payer dynamics, including managed care, specialty pharmacy, and utilization management.
Ability to analyze complex data and convert insights into strategic recommendations.
Experience operating in high ambiguity, early‑stage, or pre‑launch environments.
Benefits (W2)
Medical, dental, and vision benefits.
401(k) with company matching.
Life insurance.
EEO Statement Eliassen Group is an Equal Opportunity and affirmative action employer. All employment decisions are based on merit, performance, and business needs. Eliassen does not discriminate on the basis of race, color, gender identification or expression, sexual preference or orientation, sex, marital status, creed, religion, physical or mental disability, genetic information, veteran status, age, ancestry, national origin, citizenship status, or any other category protected by federal, state, or local laws.
#J-18808-Ljbffr
Anywhere (Remote)
Type: Contract (W2)
Industry: Life Sciences
Rate: $70.00 – $80.00 per hour (W2)
Job Overview Our client seeks a consultant to drive U.S. market access strategy and launch readiness for a rare disease asset. The role advises on payer analytics, value narrative development, and field enablement to support access decisions across commercial and government channels. The consultant will translate evidence and data into strategic recommendations and partner across functions to ensure integrated launch planning.
Responsibilities
Support development and refinement of U.S. payer strategy for rare disease assets approaching launch.
Conduct payer landscape and access risk assessments across commercial, Medicaid, and specialty payer segments.
Pressure-test launch assumptions related to access timing, utilization management, and contracting scenarios.
Provide structured recommendations on access-related risks and mitigation strategies.
Shape the payer value narrative by translating clinical, unmet need, and HEOR inputs into payer-relevant messaging.
Align the value story across national and regional payer audiences.
Identify evidence or analytics gaps that could affect payer decision‑making pre‑ and peri‑launch.
Analyze claims data, coverage policies, and utilization management trends to generate actionable insights.
Translate data into clear strategic implications for market access leadership.
Support payer segmentation and prioritization based on disease prevalence, payer controls, and policy trends.
Enable field market access and account teams with payer insights, strategic talking points, and analytics‑driven frameworks.
Advise account teams on payer motivations, objections, and decision pathways in rare disease.
Ensure field‑facing materials are strategy‑led and aligned with overall payer positioning.
Collaborate with Market Access, Medical Affairs, HEOR, and Commercial Planning to drive integrated launch readiness.
Act as a market access thought partner in a lean, fast‑moving environment.
Experience Requirements
7–12+ years in market access strategy, payer strategy, or life sciences consulting.
Experience supporting rare disease and/or orphan product launches.
Strong understanding of U.S. payer dynamics, including managed care, specialty pharmacy, and utilization management.
Ability to analyze complex data and convert insights into strategic recommendations.
Experience operating in high ambiguity, early‑stage, or pre‑launch environments.
Benefits (W2)
Medical, dental, and vision benefits.
401(k) with company matching.
Life insurance.
EEO Statement Eliassen Group is an Equal Opportunity and affirmative action employer. All employment decisions are based on merit, performance, and business needs. Eliassen does not discriminate on the basis of race, color, gender identification or expression, sexual preference or orientation, sex, marital status, creed, religion, physical or mental disability, genetic information, veteran status, age, ancestry, national origin, citizenship status, or any other category protected by federal, state, or local laws.
#J-18808-Ljbffr